-
公开(公告)号:WO2022251953A1
公开(公告)日:2022-12-08
申请号:PCT/CA2022/050868
申请日:2022-05-31
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
Inventor: KULKARNI, Jayesh , CHANDER, Nisha , BASHA, Genc , CIUFOLINI, Marco , WITZIGMANN, Dominik , CULLIS, Pieter
IPC: A61K47/24 , A61K9/14 , A61K9/51 , A61P1/16 , A61P31/12 , A61P35/00 , C07F9/10 , C12N15/10 , C12N15/87
Abstract: The present disclosure provides a lipid nanoparticle comprising encapsulated mRNA and at least 30 mol% of a sphingolipid (e.g. sphingomyelin (SM)), and at least one of a sterol and a hydrophilic polymer-lipid conjugate, the lipid nanoparticle comprising a core comprising an electron dense region and an aqueous portion surrounded at least partially by a lipid layer comprising a bilayer and the lipid nanoparticle exhibiting at least a 2-fold increase in gene expression in the liver, spleen and/or bone marrow at 4 or 24 hours post-injection as compared to a lipid nanoparticle encapsulating mRNA with an Onpattro™-type formulation of cationic, ionizable lipid/DSPC or ESM/cholesterol/PEG-lipid at 50/10/38.5/1.5, mol:mol, wherein the gene expression is measured in an animal model by detection of green fluorescent protein (GFP). Further provided are methods of medical treatment and uses of such lipid nanoparticles to treat or prevent a disease condition in a hepatic or non-hepatic tissue or organ.
-
2.
公开(公告)号:WO2022246559A1
公开(公告)日:2022-12-01
申请号:PCT/CA2022/050841
申请日:2022-05-26
Inventor: JEFFERIES, Wilfred A. , RIBECA, Paolo
IPC: C12N15/85 , A61K31/713 , A61K31/7088 , A61K39/12 , A61K48/00 , A61K49/00 , A61P31/00 , A61P31/12 , A61P37/04 , C07K14/08 , C07K14/18 , C07K14/19 , C07K14/165 , C12N15/40 , C12N15/50 , C12N15/63 , C12N15/113
Abstract: The present invention relates to an expression vector that encodes all or a portion of replicon proteins from a positive stranded virus, wherein expression of the replicon proteins is under the control of CMV and T7 promoters, and wherein expression of a payload is under the control of a sub-genomic promoter. Also provided are methods of using the vector in therapeutics and vaccines.
-
3.
公开(公告)号:WO2022193029A1
公开(公告)日:2022-09-22
申请号:PCT/CA2022/050415
申请日:2022-03-18
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
Inventor: ZHOU, Youwen
IPC: A61K31/202 , A61K31/557 , A61P17/00 , C07C59/42
Abstract: This invention provides the use of specialized pro-resolving mediators (SPMs) for use as melanocyte growth promoters and pro-survival factors. More particularly, the SPM compositions are suitable for promoting melanocyte growth and/or survival to prevent depigmentation of melanocytes and/or promoting re-pigmentation in non-inflammatory depigmentation of melanocytes. Furthermore, the compositions may be used to treat dormant vitiligo lesions, chemically induced vitiligo, vitiligo that is non-responsive to inflammatory therapies, or canities.
-
公开(公告)号:WO2022155728A1
公开(公告)日:2022-07-28
申请号:PCT/CA2022/050042
申请日:2022-01-12
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
Inventor: CIUFOLINI, Marco , FERGUSON, Mai Lam
IPC: C07C323/12 , A61K9/51 , A61K47/20 , C07C323/25 , C12N15/10 , C12N15/87
Abstract: Provided herein is a compound having a structure of Formula (I): (Formula (I)) wherein: D is S, O or an ester; p is 1 to 6; L1 and/or L2 are independently linear or branched C1-C30 alkyl, optionally having one or more C=C double bonds of E or Z geometry; and wherein: if D is S then L1 and/or L2 are unsubstituted or substituted with one or more S; and if D is O or an ester, then L1 and/or L2 are substituted with one more S. The compound may be formulated in a lipid nanoparticle for use in the delivery of charged cargo such as nucleic acid. Further provided are methods for making the compound.
-
公开(公告)号:WO2022126275A1
公开(公告)日:2022-06-23
申请号:PCT/CA2021/051826
申请日:2021-12-16
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA , PROVINCIAL HEALTH SERVICES AUTHORITY , ALPHA-9 THERANOSTICS INC. , BÉNARD, François , LIN, Kuo-shyan , ZHANG, Chengcheng , PERRIN, David , ROXIN, Aron , ZHANG, Zhengxing , DOUCHEZ, Antoine , DANESHMANDKASHANI, Pargol , LAI, Samson
Inventor: BÉNARD, François , LIN, Kuo-shyan , ZHANG, Chengcheng , PERRIN, David , ROXIN, Aron , ZHANG, Zhengxing , DOUCHEZ, Antoine , DANESHMANDKASHANI, Pargol , LAI, Samson
IPC: C07D257/02 , A61K51/04 , A61K51/08 , C07K5/06 , C07K5/037
Abstract: The present invention relates to radiolabelled compounds for in vivo imaging or treatment of diseases or conditions characterized by expression of prostate-specific membrane antigen.
-
公开(公告)号:WO2022120498A1
公开(公告)日:2022-06-16
申请号:PCT/CA2021/051787
申请日:2021-12-10
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA [CA]/[CA]
Inventor: CRIPTON, Peter Alec , CHUNG, Vivian Woan Jien , WHYTE, Thomas Christopher , BOOTH, Gabrielle Rose
IPC: A42B3/064
Abstract: Helmet prevent or mitigate cervical spine fractures, including the type of injuries associated with axial compression of the spine and fracture of the spine which may otherwise result in deformation and/or injury to the spinal cord. Helmets convert an impact force with a component aligned with the axis of the spine (a "spinally axial component") to rotational motion. In the event of a head-first impact, such helmets flexion of the neck so that the head and the cervical spine are not aligned (or less aligned) with the direction of an impact force, thereby mitigating the likelihood and/or severity of cervical spine fractures.
-
公开(公告)号:WO2022109726A1
公开(公告)日:2022-06-02
申请号:PCT/CA2021/051666
申请日:2021-11-23
Inventor: JEFFERIES, Wilfred , RIBECA, Paolo
Abstract: The present invention provides a method of epitope-based vaccine design. The method comprising: a) providing one or more target amino acid sequence(s); b) optionally discarding peptides based on one or more predetermined features; c) parsing and selecting MHC I and/or MHC II binding peptides from said sequences; and d) assembling the MHC I and/or MHC II binding peptides optionally with linkers to produce an assembly of peptides.
-
公开(公告)号:WO2022107049A1
公开(公告)日:2022-05-27
申请号:PCT/IB2021/060724
申请日:2021-11-18
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
Inventor: LI, Shyh-Dar , VISWANADHAM, KK Durgra Rao , BOETTGER, Roland
Abstract: The present invention relates to anti-nociceptive compounds and uses thereof. In some embodiments, the present invention provides LEU-ENK analogues for treating pain, anxiety, mood disorders or depression.
-
公开(公告)号:WO2022082312A1
公开(公告)日:2022-04-28
申请号:PCT/CA2021/051486
申请日:2021-10-21
Inventor: BÉNARD, François , LIN, Kuo-Shyan , ZHANG, Zhengxing , KWON, Daniel , PERRIN, David , TODOROVIC, Mihajlo , LOZADA, Jerome , LI, Lee Lee
Abstract: The present disclosure relates to peptidic compounds of Formula A, A-II, A-III, B, or C, or salt or solvate thereof, compositions thereof, and methods of use thereof. The compounds of the present disclosure are useful for targeting CXCR4 for purposes such as imaging and/or therapeutics.
-
公开(公告)号:WO2022067447A1
公开(公告)日:2022-04-07
申请号:PCT/CA2021/051378
申请日:2021-10-01
Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
Inventor: CRETU, Edmond , HERNANDEZ, Carlos Gerardo , ROHLING, Robert
Abstract: Methods, systems, and techniques for the contactless operation of capacitive micromachined ultrasonic transducers (CMUTs) and CMUT arrays. Contactless operations refers to both the contactless transfer of energy and information between the transducer(s) and the controlling subsystem. A system includes a CMUT, a first alternating current voltage source, a first inductor electrically coupled to the first voltage source, and a second inductor electrically coupled to the CMUT. The second inductor is physically decoupled from, and positioned to be wirelessly coupled to, the first inductor. A contactless configuration is useful for a wide range of applications, from wearable transducers to high-end ultrasound imaging systems.
-
-
-
-
-
-
-
-
-